Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Electronic Labeling Study By GAO Yields “No Consensus,” Avoids Cost Issue

This article was originally published in The Pink Sheet Daily

Executive Summary

In study mandated by FDASIA, GAO says there are advantages and disadvantages to switching to an electronic-only system for distributing drug label information, but offers no conclusions.

You may also be interested in...

Will Antimicrobial Breakpoint Changes Signal Shift To Online Labeling Updates?

FDA must place antimicrobial breakpoints that usually appear in labeling on a website so they can be more regularly updated. CDER Director Woodcock said that could become a precedent for other electronic labeling changes.

Priority Review Vouchers, FDA Funding Win In Omnibus Budget Deal

FY 2016 funding bill is much higher than House and Senate appropriations committee totals.

Electronic Prescribing Information: Proposed Rule May Not Completely Eliminate Paper

FDA expresses concerns about providing both paper and electronic versions of prescribing information to health care providers but seeks comments on dual systems anyway.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts